Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/09/2014US20140302146 Ophthalmic Aqueous Composition
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302142 Compositions and methds for enhancing penetration of biologically active substances into tissues or organs
10/09/2014US20140302140 Gaba analog prodrug sustained release oral dosage forms
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302138 Extended release pharmaceutical compositions containing carbamazepine
10/09/2014US20140302137 Formulation for co-therapy treatment of diabetes
10/09/2014US20140302136 Delivery system for saw palmetto extract and carotenoid
10/09/2014US20140302134 Formulation for the controlled release of one or several substances in the digestive tract of a mammal
10/09/2014US20140302132 Pharmaceutical composition comprising nanocrystals
10/09/2014US20140302131 Oral formulations containing hyaluronic acid for sustained drug release
10/09/2014US20140302129 Human lubrication gel
10/09/2014US20140302128 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
10/09/2014US20140302127 Novel formulation of metaxalone
10/09/2014US20140302126 Rhein or diacerein compositions
10/09/2014US20140302125 Methods for treating cardiovascular disorders
10/09/2014US20140302121 Cannabinoid Receptor Binding Agents, Compositions and Methods
10/09/2014US20140302118 Hydrous adhesive skin patch
10/09/2014US20140302116 Compositions and methods for nucleic acid delivery
10/09/2014US20140302115 Drug delivery system based on polyethylene vinylacetate copolymers
10/09/2014US20140302090 Novel vaccine
10/09/2014US20140302088 Compositions and methods for dengue virus chimeric constructs in vaccines
10/09/2014US20140302086 Pharmaceutical Composition Comprising Cannabinoids Having Reduced Psychoactivity through the Combination of CBD and Non-decarboxylated THC
10/09/2014US20140302067 Persimmon leaf-derived polysaccharide fraction having immune function-enhancing activity and method producing the same
10/09/2014US20140302066 Pyrrolobenzodiazepines and targeted conjugates
10/09/2014US20140302053 Compositions for the treatment of rheumatoid arthritis and methods of using same
10/09/2014US20140302052 Combination Therapy to Enhance NK Cell Mediated Cytotoxicity
10/09/2014US20140302043 Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
10/09/2014US20140302032 Monoclonal antibodies for tumor treatment
10/09/2014US20140302030 Method of combination therapy using anti-c-met antibody and sorafenib
10/09/2014US20140302022 2-carboxamide clycloamino urea derivatives for use in treating vegf-dependent diseases
10/09/2014US20140302021 Antibody formulations and methods
10/09/2014US20140302020 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
10/09/2014US20140302018 Treatment of diffuse large-cell lymphoma with anti-cd20 antibody
10/09/2014US20140302017 Treating skin cancer
10/09/2014US20140302014 Methods for the treatment of cancer using coenzyme q10 combination therapies
10/09/2014US20140302012 Combination Therapies for Treating Hematologic Malignancies Using Pyridopyrimidinone Inhibitors of PI3K/mTOR with Bendamustine and/or Rituximab
10/09/2014US20140302011 Compositions including triciribine and trastuzumab and methods of use thereof
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140302009 Medicinal Agent for Prevention or Treatment of Diseases Associated with Intraocular Neovascularization and/or Intraocular Vascular Hyperpermeability
10/09/2014US20140302000 Pharmaceutical compositions of lipase-containing products, in particular of pancreatin
10/09/2014US20140301999 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
10/09/2014US20140301996 Methods for the treatment and prevention of inflammatory diseases
10/09/2014US20140301995 Raising and Diagnosing of Serotonin Level
10/09/2014US20140301982 Complement antagonists and uses thereof
10/09/2014US20140301981 Combination Therapy with Interferon and Andrographolides for Multiple Sclerosis
10/09/2014US20140301980 Methods for the treatment of psoriatic arthritis using apremilast
10/09/2014US20140301979 Anti-arenaviral compounds
10/09/2014US20140301978 Methods for using 1,2,4-oxadiazole benzoic acid compounds
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/09/2014US20140301975 Methods for Treating Blood Disorders
10/09/2014US20140301972 Use of biocompatible polymers for the preparation of a composition or a medical device
10/09/2014US20140301971 Medical Device Comprising Boswellic Acid
10/09/2014US20140301967 Antimicrobial cationic polycarbonates
10/09/2014US20140301961 Compounds with anti-aging activities
10/09/2014US20140301955 Chitosan-derivative compounds and methods of controlling microbial populations
10/09/2014US20140301954 Mucous membrane active agent application
10/09/2014US20140301951 Porous nanoparticle supported lipid nanostructures
10/09/2014US20140301944 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
10/09/2014US20140300025 Oral disintegrating tablet
10/09/2014US20140299125 Inhaler
10/08/2014EP2787351A1 Heroin detection by raman spectroscopy from impure compositions comprising an interfering fluorescent contaminant
10/08/2014EP2787345A1 Treatment Options For Fabry Disease
10/08/2014EP2787002A1 Oleanolic acid amidate derivatives, preparation methods and uses thereof
10/08/2014EP2787001A1 (E)-3-Aryl-3-oxoprop-1-enyl-2-phosphonic acid and its derivatives, methods for their preparation and their use
10/08/2014EP2786998A1 Thienyl [3, 2-d]pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof
10/08/2014EP2786997A1 Peripheral opioid receptor antagonists and uses thereof
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2786995A1 Azaindoles useful as inhibitors of JAK and other protein kinases
10/08/2014EP2786990A1 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof
10/08/2014EP2786989A1 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof
10/08/2014EP2786986A2 Novel benzamide derivative and use thereof
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2786982A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
10/08/2014EP2786981A1 Stilbenoid compounds as inhibitors for squamous carcinoma and hepatoma and uses thereof
10/08/2014EP2786782A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis
10/08/2014EP2786758A1 Pharmaceutical composition for prevention or treatment of cognitive function disorders comprising spinosyn
10/08/2014EP2786757A1 2-substituted oleanolic acid derivative, method preparing for same, and application thereof
10/08/2014EP2786756A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786755A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786754A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786753A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786752A1 Ropinirole-containing adhesive patch
10/08/2014EP2786751A1 Genistein for use in the method of mitigating detrimental effects of exposure to ionizing radiation
10/08/2014EP2786750A1 Agent for reducing adverse side effects of kinase inhibitor
10/08/2014EP2786749A1 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
10/08/2014EP2786748A1 Transdermal therapeutic system comprising rivastigmine
10/08/2014EP2786747A1 Promoting hair growth solution containing chlorine dioxide preparation method and use method thereof
10/08/2014EP2786741A1 Whitening cosmetic
10/08/2014EP2785878A1 Reuterin-producing lactobacillus brevis
10/08/2014EP2785872A2 Materials and methods related to nsaid chemoprevention in colorectal cancer
10/08/2014EP2785840A1 Induced exon inclusion in spinal muscle atrophy
10/08/2014EP2785839A2 Expression of mirnas in placental tissue
10/08/2014EP2785766A1 Hydroxypolyamine salts
10/08/2014EP2785745A1 Method for simultaneously substituting and cross-linking a polysaccharide by means of the hydroxyl functions thereof
10/08/2014EP2785729A1 Oligonucleotides for treating expanded repeat diseases
10/08/2014EP2785721A1 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
10/08/2014EP2785720A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/08/2014EP2785719A1 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
10/08/2014EP2785717A1 Pyrazolopyrrolidine compounds
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 7860